{"count": 2, "results": [{"_id": "31672491", "pmid": 31672491, "title": "Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.", "journal": "Cancer Lett", "authors": ["Nan X", "Wang J", "Cheng H", "Yin Z", "Sheng J", "Qiu B", "Lau CC", "Yustein JT", "Zhao H", "Wong STC"], "date": "2020-01-28T00:00:00Z", "doi": "10.1016/j.canlet.2019.10.034", "meta_date_publication": "2020 Jan 28", "meta_volume": "469", "meta_issue": "", "meta_pages": "195-206", "score": 50253.26, "text_hl": "@CHEMICAL_Imatinib_Mesylate @CHEMICAL_MESH:D000068877 @@@Imatinib@@@ revives the therapeutic potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Sarcoma_Ewing</m> @DISEASE_MESH:D012512 @@@ewing sarcoma@@@ by attenuating @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ @DISEASE_Hypoxia_Brain @DISEASE_MESH:D002534 @@@hypoxic@@@ response and inhibiting convergent signaling pathways.", "citations": {"NLM": "Nan X, Wang J, Cheng H, Yin Z, Sheng J, Qiu B, Lau CC, Yustein JT, Zhao H, Wong STC. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Cancer Lett. 2020 Jan 28;469():195-206. PMID: 31672491", "BibTeX": "@article{31672491, title={Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.}, author={Nan X and Wang J and Cheng H and Yin Z and Sheng J and Qiu B and Lau CC and Yustein JT and Zhao H and Wong STC}, journal={Cancer Lett}, volume={469}, pages={195-206}}"}}, {"_id": "29100387", "pmid": 29100387, "pmcid": "PMC5652780", "title": "Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties", "journal": "Oncotarget", "authors": ["Dasgupta A", "Trucco M", "Rainusso N", "Bernardi RJ", "Shuck R", "Kurenbekova L", "Loeb DM", "Yustein JT"], "date": "2017-08-24T00:00:00Z", "doi": "10.18632/oncotarget.20467", "meta_date_publication": "2017 Sep 29", "meta_volume": "8", "meta_issue": "44", "meta_pages": "77292-77308", "score": 50059.457, "text_hl": "@CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can modulate @<m>DISEASE_Sarcoma_Ewing</m> @DISEASE_MESH:D012512 @@@Ewing sarcoma@@@ stem cell subpopulation cells", "citations": {"NLM": "Dasgupta A, Trucco M, Rainusso N, Bernardi RJ, Shuck R, Kurenbekova L, Loeb DM, Yustein JT. Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties Oncotarget. 2017 Sep 29;8(44):77292-77308. PMID: 29100387", "BibTeX": "@article{29100387, title={Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties}, author={Dasgupta A and Trucco M and Rainusso N and Bernardi RJ and Shuck R and Kurenbekova L and Loeb DM and Yustein JT}, journal={Oncotarget}, volume={8}, number={44}, pages={77292-77308}}"}}]}